Literature DB >> 34698334

Clinicopathologic and Proteomic Analysis of Amyloidomas Involving the Ocular Surface and Adnexa.

Pouya Jamshidi1, Jonathan Levi2, Maria Jose Suarez3, Roxana Rivera4, Nicholas Mahoney5, Charles G Eberhart5,6, Avi Rosenberg6, Fausto J Rodriguez5,6.   

Abstract

OBJECTIVES: Ocular amyloidoma is a rare disorder characterized by deposition of insoluble proteinaceous fibrils in the extracellular space of the ocular adnexa. This study details the clinicopathologic features and proteomic characteristics of periocular amyloid deposition.
METHODS: Specimens (1991-2020) were retrieved and reviewed. All available H&E slides and special stains were reviewed. Proteomic analysis was performed using immunohistochemistry (IHC) for IgG, IgG4, IgA, IgD, IgM, CD20, CD3, CD138, and κ/λ, as well as chromatography-electrospray tandem mass spectrometry on formalin-fixed, paraffin-embedded tissue.
RESULTS: There were 14 patients (7 men, 7 women). The depositions involved eyelid (n = 3), conjunctiva (n = 8), and orbit (n = 3). All patients were adults with a median age at diagnosis of 56 (range, 39-88) years. The deposits were predominantly λ light chain restricted (n = 6) and mixed light chains (n = 2), and one case was κ predominant. Two of the cases with a mixture of κ and λ light chains had an excess of transthyretin by mass spectrometry. Four of the cases did not have adequate material for proteomic subtyping.
CONCLUSIONS: Amyloidomas involving ocular adnexa contain a variety of amyloid-related and immunoglobulin-associated peptides. The λ light chain predominates as in other body sites, but mixed patterns and rarely κ light chain restriction may be encountered. © American Society for Clinical Pathology, 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Adnexa; Amyloid; Immunoglobulin; Mass spectrometry; Ocular

Mesh:

Substances:

Year:  2022        PMID: 34698334      PMCID: PMC8973273          DOI: 10.1093/ajcp/aqab161

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  25 in total

1.  Bifocal orbital and nasopharyngeal amyloidomas presenting as Graves disease.

Authors:  Albert Y Wu; William B Chapman; Ian J Witterick; Dan D Deangelis
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2011 Sep-Oct       Impact factor: 1.746

2.  Localized orbital amyloidosis involving the lacrimal sac and nasolacrimal duct.

Authors:  Marcus M Marcet; Joo Heon Roh; John T Mandeville; John J Woog
Journal:  Ophthalmology       Date:  2005-12-15       Impact factor: 12.079

Review 3.  Amyloidosis-where are we now and where are we heading?

Authors:  Maria M Picken
Journal:  Arch Pathol Lab Med       Date:  2010-04       Impact factor: 5.534

4.  Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines.

Authors:  Jean D Sipe; Merrill D Benson; Joel N Buxbaum; Shu-Ichi Ikeda; Giampaolo Merlini; Maria J M Saraiva; Per Westermark
Journal:  Amyloid       Date:  2016-11-24       Impact factor: 7.141

5.  Periocular and orbital amyloidosis: clinical characteristics, management, and outcome.

Authors:  Igal Leibovitch; Dinesh Selva; Robert A Goldberg; Timothy J Sullivan; Peerooz Saeed; Garry Davis; John D McCann; Alan McNab; Jack Rootman
Journal:  Ophthalmology       Date:  2006-07-07       Impact factor: 12.079

Review 6.  Manifestations of systemic light chain deposition.

Authors:  R E Randall; W C Williamson; F Mullinax; M Y Tung; W J Still
Journal:  Am J Med       Date:  1976-02       Impact factor: 4.965

7.  Generalized crystal-storing histiocytosis associated with monoclonal gammopathy: molecular analysis of a disorder with rapid clinical course and review of the literature.

Authors:  Annette Lebeau; Evelyn Zeindl-Eberhart; Eva-Christina Müller; Josef Müller-Höcker; Peter Roman Jungblut; Bertold Emmerich; Udo Löhrs
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

8.  Bilateral ptosis caused by localized superficial eyelid amyloidosis.

Authors:  Rebecca R Stack; Brendan J T Vote; Jane L Evans; Mark J Elder
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2003-05       Impact factor: 1.746

Review 9.  Amyloidosis.

Authors:  Mark B Pepys
Journal:  Annu Rev Med       Date:  2006       Impact factor: 13.739

10.  Anterior orbit and adnexal amyloidosis.

Authors:  Hailah Al Hussain; Deepak P Edward
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.